<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE ichicsr>
<ichicsr lang="en">
<ichicsrmessageheader>
<messagetype>ichicsr</messagetype>
<messageformatversion>2.1</messageformatversion>
<messageformatrelease>1.0</messageformatrelease>
<messagenumb>aaebc5f1-9ffe-11ee-a561-28dfeb6bed73-BIO</messagenumb>
<messagesenderidentifier>simplesafety</messagesenderidentifier>
<messagereceiveridentifier>ss</messagereceiveridentifier>
<messagedateformat>204</messagedateformat>
<messagedate>20221230181423</messagedate>
</ichicsrmessageheader>
<safetyreport>


<primarysourcecountry>FR</primarysourcecountry>
<occurcountry>FR</occurcountry>
<transmissiondateformat>102</transmissiondateformat>
<transmissiondate>20221230</transmissiondate>
<reporttype>1</reporttype>
<serious>1</serious>
<seriousnessdeath>2</seriousnessdeath>
<seriousnesslifethreatening>2</seriousnesslifethreatening>
<seriousnesshospitalization>1</seriousnesshospitalization>
<seriousnessdisabling>2</seriousnessdisabling>
<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
<seriousnessother>1</seriousnessother>
<receivedateformat>102</receivedateformat>
<receivedate>20221230</receivedate>
<receiptdateformat>102</receiptdateformat>
<receiptdate>20221230</receiptdate>


<duplicate>1</duplicate>
<reportduplicate>
<duplicatenumb>2022SA265631</duplicatenumb>
</reportduplicate>

<sender>

<senderorganization>simplesafety</senderorganization>
</sender>
<receiver>

<receiverorganization>ss</receiverorganization>
</receiver>
<patient>
<patientinitial>(first, last)PRIVACY</patientinitial>






<patientonsetage>62</patientonsetage>
<patientonsetageunit>801</patientonsetageunit>


<patientagegroup>6</patientagegroup>


<patientsex>1</patientsex>




<reaction>
<primarysourcereaction>Angioedema</primarysourcereaction>

<reactionmeddrallt>10002424</reactionmeddrallt>












</reaction><drug>
<drugcharacterization>1</drugcharacterization>
<medicinalproduct>#1 ) TRIATEC (RAMIPRIL) Unknown</medicinalproduct>




<drugauthorizationholder>NA</drugauthorizationholder>









<drugadministrationroute>0</drugadministrationroute>

<drugindication>10061835</drugindication>
<drugstartdateformat>102</drugstartdateformat>
<drugstartdate>sep</drugstartdate>
<drugenddateformat>102</drugenddateformat>


<drugtreatmentdurationunit>804</drugtreatmentdurationunit>

<drugrecurreadministration>3</drugrecurreadministration>

<activesubstance>
<activesubstancename>#1 ) TRIATEC (RAMIPRIL) Unknown</activesubstancename>
</activesubstance>
</drug><summary>
<narrativeincludeclinical>DescribeReaction
Event Verbatim [LOWER LEVEL TERM] (Related symptoms if any separated by commas)Other Serious Criteria: Medically SignificantAngioedema [Angioedema]Case Description: Initial information regarding this unsolicited valid serious case downloaded fromEudraVigilance database without narrative (level 2A), was received on 06-Jul-2022 from physician via HealthAuthorities of France under reference FR-AFSSAPS-MA20222708. The following narrative is based on theinformation retrieved from all other accessible data.(Continued on Additional Information Page)
OtherRelevantHistory
From/To Dates Type of History / Notes - â€œDescriptionUnknown
MFRControlNo

ConcomitantDrugs

IndicationForUse
#1 ) Diabetic nephropathy (Diabetic nephropathy)</narrativeincludeclinical>
</summary></patient></safetyreport>
</ichicsr>